U.S. Other Utilities Stock News

In February 2026, Aurinia Pharmaceuticals reported fourth-quarter 2025 revenue of US$77.11 million and full-year revenue of US$283.06 million, alongside a very large increase in net income and earnings per share versus 2024. On the same day, the company issued 2026 guidance calling for total revenue of US$315 million to US$325 million and net product sales of US$305 million to US$315 million, signaling management’s confidence in its operating momentum and product demand. We’ll now examine...

In late February 2026, Mason Capital Management LLC disclosed a new position in Borr Drilling Limited, acquiring about 2.18 million shares valued at roughly US$8.79 million. This new holding, representing around 1.57% of Mason Capital’s reportable assets, highlights growing institutional interest in Borr Drilling’s balance sheet progress and contract exposure. With Mason Capital’s fresh stake now in place, we’ll examine how increased institutional ownership reshapes Borr Drilling’s...

Why Iovance Biotherapeutics Has Caught Investor Attention Iovance Biotherapeutics (IOVA) has drawn fresh interest after recent trading sessions, as investors weigh its commercial stage cell therapy profile alongside sharp moves in the share price over the past month. The stock shows a 103% return over the past month and 128% over the past 3 months, placing recent momentum against a backdrop that includes revenue of US$263.502 million and a net loss of US$390.978 million. See our latest...

Tremco, a unit of RPM International (NYSE:RPM), has agreed to acquire Kalzip GmbH. The deal brings Kalzip’s aluminum building envelope systems into RPM’s building solutions portfolio. The acquisition is expected to expand RPM’s reach across Europe, India, and North America. RPM International, through its Tremco segment, focuses on building envelope products such as roofing, waterproofing, and related systems. Adding Kalzip’s metal roofing and façade solutions fits within that core line of...

Why the latest 10-K filing matters for PureCycle Technologies (PCT) PureCycle Technologies (PCT) just filed its latest 10-K, and auditor Grant Thornton issued an unqualified opinion while also expressing doubt about the company’s ability to continue as a going concern, putting financial stability in sharper focus for shareholders. See our latest analysis for PureCycle Technologies. PureCycle’s recent earnings update, plans for a European facility and an upcoming maintenance outage are all...

Why Owens Corning (OC) just drew fresh investor attention Owens Corning (OC) has moved back into focus after reporting fourth quarter and full year 2025 results that showed lower sales, larger losses, and new revenue guidance for the upcoming quarter. The company reported fourth quarter 2025 sales of US$2,142 million compared with US$2,574 million a year earlier, alongside a net loss of US$298 million versus a loss of US$258 million in the prior year period. See our latest analysis for Owens...

SK hynix and Sandisk announced a new alliance to standardize and commercialize High Bandwidth Flash, or HBF, memory for AI inference workloads. The effort targets a new memory tier between high performance HBM and high capacity SSDs. It aims to support growing demand from AI data centers. The companies are forming an industry consortium to push a global HBF standard and accelerate adoption across AI infrastructure vendors. For investors tracking NasdaqGS:SNDK, this move sits at the...

Omada Health (OMDA) is back in focus after reporting its first GAAP profitable quarter, alongside revenue growth in 2025 and improved margins, while also rolling out its GLP-1 Flex Care program for employers. See our latest analysis for Omada Health. The recent earnings beat, first GAAP profitable quarter and launch of GLP-1 Flex Care have coincided with a 20.6% 1 month share price return. However, the negative 90 day and year to date share price returns suggest momentum has only recently...

In the past week, AppLovin detailed its shift from a mobile gaming ad network to an AI-driven performance marketing platform, highlighting Axon 2.0, new generative AI ad tools, and an expanding self-service e-commerce offering at events including the Morgan Stanley Technology, Media & Telecom Conference in San Francisco. Management and analysts now see AppLovin’s push into e-commerce, including AI-generated video ads and dynamic product catalogs, as a key driver of its broader advertising...

In late February 2026, SoundHound AI reported Q4 2025 sales of US$55.06 million and full-year 2025 revenue of US$168.92 million, alongside a swing from a prior-year net loss of US$350.68 million to a much smaller US$14.01 million loss. Soon after, the company paired this record performance with a new US$168.05 million shelf registration tied to employee stock plans and an upbeat 2026 revenue outlook of US$225–US$260 million, underscoring how internal ownership incentives and growth...

In early March 2026, multiple investor law firms disclosed securities class action lawsuits against Apollo Global Management, alleging that senior leaders misled the market about past business communications with Jeffrey Epstein and the associated reputational risk. The complaints center on claims that Apollo’s prior assurances of no business ties to Epstein were inconsistent with reported tax-related consultations, raising questions about the reliability of earlier disclosures and...

Event context and recent share performance Installed Building Products (IBP) shares have recently pulled back from earlier levels, with the stock showing a 2.1% decline over the past day and a 6.3% decline over the past week. See our latest analysis for Installed Building Products. Even with the recent softness in the share price, including a 7% 30 day share price return decline, Installed Building Products still has a 15% 90 day share price return and a 74% 1 year total shareholder return...

EchoStar Corporation recently reported full-year 2025 results showing revenue of US$15.00 billion, down from US$15.83 billion a year earlier, alongside a sharply higher net loss of US$14.50 billion and basic and diluted loss per share from continuing operations of US$50.41, compared with US$0.44 previously. On the same day, auditor KPMG issued an unqualified opinion with a going concern warning in EchoStar’s 10-K, highlighting serious doubt about the company’s ability to remain financially...

American Eagle Outfitters recently reported fourth-quarter and full-year 2025 results, with sales rising to US$1,760.83 million for the quarter and US$5,496.81 million for the year, while net income and earnings per share declined; the company also declared a US$0.125 per-share quarterly dividend payable on April 24, 2026, and continued its buyback program, repurchasing 1,000,000 shares for US$25 million. Management paired this performance with guidance calling for high single-digit...

In recent months, Consolidated Edison has reported updated guidance, capital and financing plans, and seen analysts lift earnings estimates while maintaining a generally cautious stance on the stock. At the same time, the utility has faced scrutiny over prolonged winter power outages and reimbursement disputes, underscoring the operational and regulatory challenges that sit alongside its improving earnings outlook. We’ll now examine how this combination of a brighter earnings outlook and...

CenterPoint Energy (CNP) is back in focus after fourth quarter 2025 earnings matched expectations, the company reaffirmed its 2026 non GAAP earnings guidance, detailed new grid projects, and announced a 9% dividend increase. See our latest analysis for CenterPoint Energy. Recent earnings, grid investment plans and the 9% dividend increase have come alongside firm share price momentum, with a 30 day share price return of 8.89% and a 1 year total shareholder return of 29.59% that extends to...

If you are wondering whether Corvus Pharmaceuticals' recent share price puts it at a bargain or a stretched level, you are not alone. This article is here to unpack what that current price might mean for value focused investors. The stock has been volatile, with a 7 day return of an 11.7% decline and a 30 day return of a 22.8% decline, set against a year to date return of 115.8% and a 1 year return of 271.6%, plus an increase of more than 7x over 3 years and 381.6% over 5 years. Recent...

Revolve Group, Inc. recently launched Revolve Los Angeles, its first namesake fashion house inspired by its hometown, offering couture-influenced womenswear priced between US$200 and US$3,500 in sizes XXS to XL, available exclusively on Revolve and FWRD. This move expands Revolve’s in-house brand portfolio into higher-end, craftsmanship-focused apparel, signalling a push to deepen brand identity and capture more luxury-oriented spending. We’ll now explore how this higher-end Revolve Los...

In recent days, Essex Property Trust’s fourth-quarter 2025 results came in below expectations while the company’s board approved a 0.8% annual dividend increase, marking its 32nd consecutive year of dividend growth. At the same time, a mix of cautious analyst commentary and industry concerns about below pre-COVID multifamily occupancy levels has sharpened investor focus on how Essex balances income stability with near-term operational challenges. Next, we’ll examine how Essex’s earnings...

Why Celcuity (CELC) is Drawing Fresh Attention Celcuity (CELC) has come into focus after recent share price moves and its role as a clinical-stage biotechnology company working on targeted therapies for solid tumors, including advanced breast and prostate cancers. See our latest analysis for Celcuity. The current US$115.0 share price comes after a 6.2% 7 day share price return and an 11.9% 90 day share price return. The 1 year total shareholder return is very large, hinting that recent moves...

Why Denali’s recent earnings and shelf registration matter for shareholders Denali Therapeutics (DNLI) has drawn fresh attention after reporting a wider fourth quarter and full year 2025 loss alongside a new US$200.7 million shelf registration for common stock, raising questions about dilution and funding plans. For the fourth quarter, Denali reported a net loss of US$128.55 million, with basic and diluted loss per share from continuing operations of US$0.73, compared with US$0.67 a year...

In early March 2026, Incyte received European Commission approval for Zynyz (retifanlimab) plus carboplatin and paclitaxel as first-line treatment for adult patients with metastatic or inoperable locally recurrent squamous cell carcinoma of the anal canal, based on Phase 3 POD1UM-303 data showing improved progression-free survival versus chemotherapy alone. This second European indication for Zynyz strengthens Incyte’s immuno-oncology portfolio in a rare cancer setting, underpinned by...

Why Bob's Discount Furniture Is On Investors' Radar Bob's Discount Furniture (BOBS) has drawn attention after a sharp 5.5% decline in the latest session, extending a roughly 18% slide over the past week. At the same time, the share price shows a small gain over the past month and a modest positive return so far this year, giving investors mixed signals on short term sentiment. See our latest analysis for Bob's Discount Furniture. The recent 1 day share price return of a 5.46% decline and 7...

Avnet (AVT) has been drawing attention after recent share price moves, with the stock showing mixed returns over the past week and month while remaining higher over the past 3 months and year. See our latest analysis for Avnet. That pullback, with a 1 month share price return of 9.86% decline and a 1 week share price return of 7.59% decline, comes after a stronger run that leaves Avnet with a 1 year total shareholder return of 24.26% and 3 year total shareholder return of 53.29%. This...